Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population

Abstract

Elevated ALT is common among patients with AF, although new and persistent elevation greater than twice the ULN is uncommon. In the setting of a new drug, these factors make it difficult to delineate drug-induced liver injury from incident elevations due to comorbidities.